Abstract
Cardiovascular diseases (CVD) are among the leading causes of death and disability worldwide. Pregnancy-associated plasma protein-A (PAPP-A) is a matrix metalloprotease localized on the cell surface. One of the substrates that PAPP-A cleaves is the insulin-like growth factor binding protein-4 (IGFBP-4), a member of the family of proteins that bind insulin-like growth factor (IGF). Proteolysis of IGFBP-4 by PAPP-A occurs at a specific site resulting in formation of two proteolytic fragments – N-terminal IGFBP-4 (NT-IGFBP-4) and C-terminal IGFBP-4 (CT-IGFBP-4), and leads to the release of IGF activating various cellular processes including migration, proliferation, and cell growth. Increased levels of the proteolytic IGFBP-4 fragments correlate with the development of CVD complications and increased risk of death in patients with the coronary heart disease, acute coronary syndrome, and heart failure. However, there is no direct evidence that PAPP-A specifically cleaves IGFBP-4 in the cardiac tissue under normal and pathological conditions. In the present study, using a primary culture of rat neonatal cardiomyocytes as a model, we have demonstrated that: 1) proteolysis of IGFBP-4 by PAPP-A occurs in the conditioned medium of cardiomyocytes, 2) PAPP-A-specific IGFBP-4 proteolysis is increased when cardiomyocytes are transformed to a hypertrophic state. Thus, it can be assumed that the enhancement of IGFBP-4 cleavage by PAPP-A and hypertrophic changes in cardiomyocytes accompanying CVD are interrelated, and PAPP-A appears to be one of the activators of the IGF-dependent processes in normal and hypertrophic-state cardiomyocytes.
Similar content being viewed by others
Abbreviations
- ACS:
-
acute coronary syndrome
- BNP:
-
natriuretic peptide type B
- CT-IGFBP-4:
-
C-terminal proteolytic IGFBP-4 fragment
- CVD:
-
cardiovascular deceases
- DAPI:
-
4′,6-diamidino-2-phenylindole
- dPAPP-A:
-
PAPP-A, dimeric form
- HF:
-
heart failure
- IGF:
-
insulin-like growth factor
- IGFBP-2-5:
-
insulin growth factor binding protein 2-5
- NT-IGFBP-4:
-
N-terminal proteolytic IGFBP-4 fragment
- PAPP-A:
-
pregnancy associated plasma protein A
References
Bhatnagar, P., Wickramasinghe, K., Williams, J., Rayner, M., and Townsend, N. (2015) The epidemiology of cardiovascular disease in the UK 2014, Heart, 101, 1182-1189, https://doi.org/10.1136/heartjnl-2015-307516.
Rame, J. E., and Dries, D. L. (2007) Heart failure and cardiac hypertrophy, Curr. Treat. Options Cardiovasc. Med., 9, 289-301, https://doi.org/10.1007/s11936-007-0024-3.
Shimizu, I., and Minamino, T. (2016) Physiological and pathological cardiac hypertrophy, J. Mol. Cell Cardiol., 97, 245-262, https://doi.org/10.1016/j.yjmcc.2016.06.001.
Hjortebjerg, R. (2018) IGFBP-4 and PAPP-A in normal physiology and disease, Growth Horm. IGF Res., 41, 7-22, https://doi.org/10.1016/j.ghir.2018.05.002.
Lin, T. M., Halbert, S. P., and Spellacy, W. N. (1974) Measurement of pregnancy-associated plasma proteins during human gestation, J. Clin. Invest., 54, 576-582, https://doi.org/10.1172/JCI107794.
Overgaard, M. T., Sorensen, E. S., Stachowiak, D., Boldt, H. B., Kristensen, L., Sottrup-Jensen, L., and Oxvig, C. (2003) Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment, J. Biol. Chem., 278, 2106-2117, https://doi.org/10.1074/jbc.M208777200.
Oxvig, C. (2015) The role of PAPP-A in the IGF system: location, location, location, J. Cell. Commun. Signal., 9, 177-187, https://doi.org/10.1007/s12079-015-0259-9.
Monget, P., Mazerbourg, S., Delpuech, T., Maurel, M. C., Manière, S., et al. (2003) Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation, Biol. Reprod., 68, 77-86, https://doi.org/10.1095/biolreprod.102.007609.
Byun, D., Mohan, S., Yoo, M., Sexton, C., Baylink, D. J., and Qin, X. (2001) Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro, J. Clin. Endocrinol. Metab., 86, 847-854, https://doi.org/10.1210/jcem.86.2.7223.
Gyrup, C., and Oxvig, C. (2007) Quantitative analysis of insulin-like growth factor-modulated proteolysis of insulin-like growth factor binding protein-4 and -5 by pregnancy-associated plasma protein-A, Biochemistry, 46, 1972-1980, https://doi.org/10.1021/bi062229i.
Lindsay, C. R., and Evans, T. J. (2008) The insulin-like growth factor system and its receptors: a potential novel anticancer target, Biologics, 2, 855-864, https://doi.org/10.2147/btt.s3841.
Lawrence, J. B., Oxvig, C., Overgaard, M. T., Sottrup-Jensen, L., Gleich, G. J., et al. (1999) The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A, Proc. Natl. Acad. Sci. USA, 96, 3149-3153, https://doi.org/10.1073/pnas.96.6.3149.
Bayes-Genis, A., Conover, C. A., Overgaard, M. T., Bailey, K. R., Christiansen, M., et al. (2001) Pregnancy-associated plasma protein A as a marker of acute coronary syndromes, N. Engl. J. Med., 345, 1022-1029, https://doi.org/10.1056/NEJMoa003147.
Postnikov, A. B., Smolyanova, T. I., Kharitonov, A. V., Serebryanaya, D. V., Kozlovsky, S. V., et al. (2012) N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia, Clin. Biochem., 45, 519-524, https://doi.org/10.1016/j.clinbiochem.2011.12.030.
Hjortebjerg, R., Tarnow, L., Jorsal, A., Parving, H.-H., Rossing, P., Bjerre, M., and Frystyk, J (2015) IGFBP-4 fragments as markers of cardiovascular mortality in type 1 diabetes patients with and without nephropathy, J. Clin. Endocrin. Metab., 100, 3032-3040, https://doi.org/10.1210/jc.2015-2196.
Konev, A. A., Kharitonov, A. V., Rozov, F. N., Altshuler, E. P., Serebryanaya, D. V., et al. (2020) CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure, ESC Heart Fail., 7, 434-444, https://doi.org/10.1002/ehf2.12590.
Stepanova, O. V., Chadin, A. V., Kulikova, T. G., Masenko, V. P., and Tereschenko, S. N. (2012) The role of Rho-associated kinase in the formation of myofibrils and contractility of cardiomyocytes, Kardiol. Vestnik, 7, 10-14.
Laursen, L. S., Overgaard, M. T., Søe, R., Boldt, H. B., Sottrup-Jensen, L., et al. (2001) Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A, FEBS Lett., 504, 36-40, https://doi.org/10.1016/s0014-5793(01)02760-0.
Semenov, A. G., Tamm, N. N., Apple, F. S., Schulz, K. M., Love, S. A., et al. (2017) Searching for a BNP standard: glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays, Clin. Biochem., 50, 181-185, https://doi.org/10.1016/j.clinbiochem.2016.11.003.
Conover, C. A., Oxvig, C., Overgaard, M. T., Christiansen, M., and Giudice, L. C. (1999) Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A, J. Clin. Endocrinol. Metab., 84, 4742-4745, https://doi.org/10.1210/jcem.84.12.6342.
Mazerbourg, S., Overgaard, M. T., Oxvig, C., Christiansen, M., Conover, C. A., et al. (2001) Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development, Endocrinology, 142, 5243-5253, https://doi.org/10.1210/endo.142.12.8517.
Conover, C. A., Faessen, G. F., Ilg, K. E., Chandrasekher, Y. A., Christiansen, M., et al. (2001) Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum, Endocrinology, 142, 2155, https://doi.org/10.1210/endo.142.5.8286.
Bayes-Genis, A., Schwartz, R. S., Lewis, D. A., Overgaard, M. T., Christiansen, M., et al. (2001) Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty, Arterioscler. Thromb. Vasc. Biol., 21, 335-341, https://doi.org/10.1161/01.atv.21.3.335.
Giudice, L. C., Conover, C. A., Bale, L., Faessen, G. H., Ilg, K., et al. (2002) Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation, J. Clin. Endocrinol. Metab., 87, 2359-2366, https://doi.org/10.1210/jcem.87.5.8448.
Conover, C. A., Bale, L. K., Frye, R. L., and Schaff, H. V. (2019) Cellular characterization of human epicardial adipose tissue: highly expressed PAPP-A regulates insulin-like growth factor I signaling in human cardiomyocytes, Physiol. Rep., 7, e14006, https://doi.org/10.14814/phy2.14006.
Conover, C. A., Harrington, S. C., Bale, L. K. (2008) Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells, Growth Horm. IGF Res., 18, 213-20, https://doi.org/10.1016/j.ghir.2007.09.001.
D’Elia, P., Ionta, V., Chimenti, I., Angelini, F., Miraldi, F., et al. (2013) Analysis of pregnancy-associated plasma protein A production in human adult cardiac progenitor cells, BioMed Res. Int., 2013, 190178, https://doi.org/10.1155/2013/190178.
Banerjee, I., Fuseler, J. W., Price, R. L., Borg, T. K., and Baudino, T. A. (2007) Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse, Am. J. Physiol. Heart Circ. Physiol., 293, H1883-H1891, https://doi.org/10.1152/ajpheart.00514.2007.
Laursen, L. S., Kjaer-Sorensen, K., Andersen, M. H., and Oxvig, C. (2007) Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5, Mol. Endocrinol., 21, 1246-1257, https://doi.org/10.1210/me.2006-0522.
Laursen, L. S., Overgaard, M. T., Nielsen, C. G., Boldt, H. B., Hopmann, K. H., et al. (2002) Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis, Biochem. J., 367, 31-40, https://doi.org/10.1042/BJ20020831.
Ryall, K. A., Saucerman, J. J. (2012) Automated imaging reveals a concentration dependent delay in reversibility of cardiac myocyte hypertrophy, J. Mol. Cell. Cardiol., 53, 282-290, https://doi.org/10.1016/j.yjmcc.2012.04.016.
Archer, C. R., Robinson, E. L., Drawnel, F. M., and Roderick, H. L. (2017) Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors, Cell Signal., 36, 240-254, https://doi.org/10.1016/j.cellsig.2017.04.010.
Jen, H. L., Yin, W. H., Chen, J. W., and Lin, S. J. (2017) Endothelin-1-induced cell hypertrophy in cardiomyocytes is improved by fenofibrate: possible roles of adiponectin, J. Atheroscler. Thromb., 24, 508-517, https://doi.org/10.5551/jat.36368.
Higazi, D. R., Fearnley, C. J., Drawnel, F. M., Talasila, A., Corps, E. M., et al. (2009) Ca2+ release is a nexus for hypertrophic signaling in cardiac myocytes, Mol. Cell, 33, 472-482, https://doi.org/10.1016/j.molcel.2009.02.005.
Yue, T. L., Gu, J. L., Wang, C., Reith, A. D., Lee, J. C., et al. (2000) Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy, J. Biol. Chem., 275, 37895-37901, https://doi.org/10.1074/jbc.M007037200.
Yamazaki, T., Komuro, I., Kudoh, S., Zou, Y., Shiojima, I., et al. (1996) Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy, J. Biol. Chem., 271, 3221-3228, https://doi.org/10.1074/jbc.271.6.3221.
Nakahashi, T., Fukuo, K., Inoue, T., Morimoto, S., Hata, S., et al. (1995) Endothelin-1 enhances nitric oxide-induced cytotoxicity in vascular smooth muscle, Hypertension, 25, 744-747, https://doi.org/10.1161/01.hyp.25.4.744.
Piacentini, L., Gray, M., Honbo, N. Y., Chentoufi, J., Bergman, M., Karliner, J. S. (2000) Endothelin-1 stimulates cardiac fibroblast proliferation through activation of protein kinase C, J. Mol. Cell Cardiol., 32, 565-576, https://doi.org/10.1006/jmcc.2000.1109.
Hjortebjerg, R., Lindberg, S., Pedersen, S., Mogelvang, R., Jensen, J. S., et al. (2017) Insulin‐like growth factor binding protein 4 fragments provide incremental prognostic Information on cardiovascular events in patients with ST‐segment elevation myocardial infarction, J. Am. Heart Assoc., 6, e005358, https://doi.org/10.1161/JAHA.116.005358.
Makkos, A., Szántai, Á., Pálóczi, J., Pipis, J., Kiss, B., et al. (2020) A Comorbidity model of myocardial ischemia/reperfusion injury and hypercholesterolemia in rat cardiac myocyte cultures, Front. Physiol., 10, 1564, https://doi.org/10.3389/fphys.2019.01564.
Ariyasinghe, N. R., Lyra-Leite, D. M., and McCain, M. L. (2018) Engineering cardiac microphysiological systems to model pathological extracellular matrix remodeling, Am. J. Physiol. Heart Circ. Physiol., 315, H771-H789, https://doi.org/10.1152/ajpheart.00110.2018.
Belostotskaya, G. B., and Golovanova, T. A. (2014) Characterization of contracting cardiomyocyte colonies in the primary culture of neonatal rat myocardial cells: a model of in vitro cardiomyogenesis, Cell Cycle, 13, 910-918, https://doi.org/10.4161/cc.27768.
Higashi, Y., Gautam, S., Delafontaine, P., and Sukhanov, S. (2019) IGF-1 and cardiovascular disease, Growth Horm. IGF Res., 45, 6-16, https://doi.org/10.1016/j.ghir.2019.01.002.
Mohamed-Ali, V., and Pinkney, J. (2002) Therapeutic potential of insulin-like growth factor-1 in patients with diabetes mellitus, Treat. Endocrinol., 1, 399-410, https://doi.org/10.2165/00024677-200201060-00005.
Sádaba, M. C., Martín-Estal, I., Puche, J. E., and Castilla-Cortázar, I. (2016) Insulin-like growth factor 1 (IGF-1) therapy: mitochondrial dysfunction and diseases, Biochim. Biophys. Acta, 1862, 1267-1278, https://doi.org/10.1016/j.bbadis.2016.03.010.
Vinciguerra, M., Santini, M. P., Claycomb, W. C., Ladurner, A. G., and Rosenthal, N. (2009) Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity, Aging (Albany NY), 2, 43-62, https://doi.org/10.18632/aging.100107.
Yeves, A. M., Burgos, J. I., Medina, A. J., Villa-Abrille, M. C., and Ennis, I. L. (2018) Cardioprotective role of IGF-1 in the hypertrophied myocardium of the spontaneously hypertensive rats: a key effect on NHE-1 activity, Acta Physiol. (Oxf), 224, e13164, https://doi.org/10.1111/apha.13092.
Sui, Y., Zhang, W., Tang, T., Gao, L., Cao, T., et al. (2020) Insulin-like growth factor-II overexpression accelerates parthenogenetic stem cell differentiation into cardiomyocytes and improves cardiac function after acute myocardial infarction in mice, Stem Cell Res. Ther., 11, 86, https://doi.org/10.1186/s13287-020-1575-4.
Lin, M., Liu, X., Zheng, H., Huang, X., Wu, Y., et al. (2020) IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway, Stem Cell Res. Ther., 11, 22, https://doi.org/10.1186/s13287-019-1544-y.
Adachi, S., Ito, H., Akimoto, H., Tanaka, M., Fujisaki, H., et al. (1994) Insulin-like growth factor-II induces hypertrophy with increased expression of muscle specific genes in cultured rat cardiomyocytes, J. Mol. Cell. Cardiol., 26, 789-795, https://doi.org/10.1006/jmcc.1994.1096.
Carrasco, L., Cea, P., Rocco, P., Peña-Oyarzún, D., Rivera-Mejias, P., et al. (2014) Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1, J. Cell Biochem., 115, 712-720, https://doi.org/10.1002/jcb.24712.
Ito, H., Hiroe, M., Hirata, Y., Tsujino, M., Adachi, S., et al. (1993) Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes, Circulation, 87, 1715-1721, https://doi.org/10.1161/01.cir.87.5.1715.
Huang, C. Y., Hao, L. Y., and Buetow, D. E. (2002) Insulin-like growth factor-II induces hypertrophy of adult cardiomyocytes via two alternative pathways, Cell. Biol. Int., 26, 737-739, https://doi.org/10.1006/cbir.2002.0919.
Acknowledgments
The authors express their sincere gratitude to Doctor of Biological Sciences, Professor N. B. Gusev and V. E. Adashev for valuable remarks and comments that significantly improved the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflicts of interest in financial or any other sphere. All applicable international, national and/or institutional guidelines for the care and use of animals have been followed.
Rights and permissions
About this article
Cite this article
Serebryanaya, D.V., Adasheva, D.A., Konev, A.A. et al. IGFBP-4 Proteolysis by PAPP-A in a Primary Culture of Rat Neonatal Cardiomyocytes under Normal and Hypertrophic Conditions. Biochemistry Moscow 86, 1395–1406 (2021). https://doi.org/10.1134/S0006297921110043
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297921110043